Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135,833 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR.
Schanda N, Sauer T, Kunz A, Hückelhoven-Krauss A, Neuber B, Wang L, Hinkelbein M, Sedloev D, He B, Schubert ML, Müller-Tidow C, Schmitt M, Schmitt A. Schanda N, et al. Among authors: wang l. Cells. 2021 Nov 17;10(11):3208. doi: 10.3390/cells10113208. Cells. 2021. PMID: 34831430 Free PMC article.
Improvement of in vitro potency assays by a resting step for clinical-grade chimeric antigen receptor engineered T cells.
Wang L, Gong W, Wang S, Neuber B, Sellner L, Schubert ML, Hückelhoven-Krauss A, Kunz A, Gern U, Michels B, Hinkelbein M, Mechler S, Richter P, Müller-Tidow C, Schmitt M, Schmitt A. Wang L, et al. Among authors: wang s. Cytotherapy. 2019 May;21(5):566-578. doi: 10.1016/j.jcyt.2019.02.013. Epub 2019 Mar 23. Cytotherapy. 2019. PMID: 30910382
Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T Cells.
Yang M, Wang L, Ni M, Neuber B, Wang S, Gong W, Sauer T, Sellner L, Schubert ML, Hückelhoven-Krauss A, Hong J, Zhu L, Kleist C, Eckstein V, Müller-Tidow C, Dreger P, Schmitt M, Schmitt A. Yang M, et al. Among authors: wang l, wang s. Front Immunol. 2020 Dec 9;11:608167. doi: 10.3389/fimmu.2020.608167. eCollection 2020. Front Immunol. 2020. PMID: 33362794 Free PMC article.
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy.
Yang M, Wang L, Ni M, Neuber B, Wang S, Gong W, Sauer T, Schubert ML, Hückelhoven-Krauss A, Xia R, Ge J, Kleist C, Eckstein V, Sellner L, Müller-Tidow C, Dreger P, Schmitt M, Schmitt A. Yang M, et al. Among authors: wang l, wang s. Front Immunol. 2021 May 26;12:670088. doi: 10.3389/fimmu.2021.670088. eCollection 2021. Front Immunol. 2021. PMID: 34122428 Free PMC article.
Comparison of FACS and PCR for Detection of BCMA-CAR-T Cells.
Reichman A, Kunz A, Joedicke JJ, Höpken UE, Keib A, Neuber B, Sedloev D, Wang L, Jiang G, Hückelhoven-Krauss A, Eberhardt F, Müller-Tidow C, Wermke M, Rehm A, Schmitt M, Schmitt A. Reichman A, et al. Among authors: wang l. Int J Mol Sci. 2022 Jan 14;23(2):903. doi: 10.3390/ijms23020903. Int J Mol Sci. 2022. PMID: 35055086 Free PMC article.
Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patients.
Schubert ML, Berger C, Kunz A, Schmitt A, Badbaran A, Neuber B, Zeschke S, Wang L, Riecken K, Hückelhoven-Krauss A, Müller I, Müller-Tidow C, Dreger P, Kröger N, Ayuk FA, Schmitt M, Fehse B. Schubert ML, et al. Among authors: wang l. Int J Oncol. 2022 May;60(5):48. doi: 10.3892/ijo.2022.5338. Epub 2022 Mar 16. Int J Oncol. 2022. PMID: 35294040 Free PMC article.
Side-effect management of chimeric antigen receptor (CAR) T-cell therapy.
Schubert ML, Schmitt M, Wang L, Ramos CA, Jordan K, Müller-Tidow C, Dreger P. Schubert ML, et al. Among authors: wang l. Ann Oncol. 2021 Jan;32(1):34-48. doi: 10.1016/j.annonc.2020.10.478. Epub 2020 Oct 21. Ann Oncol. 2021. PMID: 33098993 Free article. Review.
135,833 results
You have reached the last available page of results. Please see the User Guide for more information.